Polyarthritis spectrum disorders managed by ayurvedic formulation arthocon: A clinical case series

Polyarthritis encompasses a broad range of joint disorders, including autoimmune, degenerative and crystal-induced types. Conventional treatments often involve long-term NSAIDs or immunosuppressants, with significant side effects. In this case series, fifteen adult patients (age 29 to 63 years; both male and female) with confirmed diagnoses of RA, PsA, SLE, AS, OA and polyarticular gout were enrolled and treated with ArthoconTM Capsule (500 mg BID) and topical ArthoconTM Oil for 12 weeks. Mean joint count decreased from 11.5 to 3.8, swelling index from 8.9 to 2.1 and VAS pain scores from 7.3 to 2.8. Disease activity scores improved significantly: DAS28 (mean reduction 2.9), PASDAS (mean reduction 3.2), SLEDAI (mean reduction 6.0), BASDAI (mean reduction 3.1), WOMAC (mean reduction 34.7) and SUA in gout patients (mean reduction 1.9 mg/dL) without any major adverse effects. The Ayurvedic combination of ArthoconTM Capsule and Oil demonstrated promising results across different arthritis types, suggesting its potential as a safe and effective integrative approach in the management of chronic joint disorders.